reports
ACCELERON PHARMA reduced its risk exposure resulting in an upgrade to ...
ACCELERON PHARMA (US), a company active in the Biotechnology industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date September 21, 2021, the closing price ...
Acceleron Pharma Inc: 1 director sold after exercising options/sold
A director at Acceleron Pharma Inc sold after exercising options/sold 11,864 shares at 140.185USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direc...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 Testing Key Resistance As we have outlined in recent weeks, our base case continues to be for near-term consolidation while the market is in a “wait-and-see†phase as it relates to states re-opening. The S&P 500 is again testing key resistance at the 61.8% Fibonacci retracement level of 2934.49 and also the 2950-3000 level we previously identified. We continue to have concerns that lead us to believe the market is not yet out of the woods, however these concerns are counterbalanced ...
LOGI LOGITECH INTERNATIONAL S.A.
NOW SERVICENOW INC.
XLRN ACCELERON PHARMA INC
WST WEST PHARMACEUTICAL SERVICES INC.
WIX WIX.COM LTD.
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TWOU 2U INC.
TECH BIO-TECHNE CORPORATION
STMP STAMPS.COM INC.
SRPT SAREPTA THERAPEUTICS INC.
SPLK SPLUNK INC.
SP8 SPARTAN MOTORS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
RRC RANGE RESOURCES CORPORATION
RNG RINGCENTRAL INC. CLASS A
QDEL QUIDEL CORPORATION
PRLB PROTO LABS INC.
PODD INSULET CORPORATION
NVDA NVIDIA CORPORATION
NERV MINERVA NEUROSCIENCES
NDSN NORDSON CORPORATION
NBIX NEUROCRINE BIOSCIENCES INC.
MPWR MONOLITHIC POWER SYSTEMS INC.
LOPE GRAND CANYON EDUCATION INC.
IPHI INPHI CORPORATION
IPGP IPG PHOTONICS CORPORATION
IIVI II-VI INCORPORATED
IDXX IDEXX LABORATORIES INC.
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
HALO HALOZYME THERAPEUTICS INC.
FTNT FORTINET INC.
FFIV F5 NETWORKS INC.
FAST FASTENAL COMPANY
ECOM CHANNELADVISOR CORP
EBS EMERGENT BIOSOLUTIONS INC.
CTSO CYTOSORBENTS
CTMX CYTOMX THERAPEUTICS INC.
CTLT CATALENT INC
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CGNX COGNEX CORPORATION
AUDC AUDIOCODES LTD.
ATVI ACTIVISION BLIZZARD INC.
ATRC ATRICURE INC.
AMPH AMPHASTAR PHARMACEUTICALS INC
ALRM ALARM.COM HOLDINGS INC.
ALLT ALLOT LTD
AKBA AKEBIA THERAPEUTICS INC.
ABMD ABIOMED INC.
IRBT IROBOT CORPORATION
ENB. ENBRIDGE INC.
SWKS SKYWORKS SOLUTIONS INC.
AEM. AGNICO EAGLE MINES LIMITED
ACLS AXCELIS TECHNOLOGIES INC.
BIO BIO-RAD LABORATORIES INC. CLASS A
ENPH ENPHASE ENERGY INC.
ENTG ENTEGRIS INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
THO THOR INDUSTRIES INC.
TREX TREX COMPANY INC.
CENTA CENTRAL GARDEN & PET CO A
EVBG EVERBRIDGE INC.
UTHR UNITED THERAPEUTICS CORPORATION
X UNITED STATES STEEL CORPORATION
COUP COUPA SOFTWARE INC.
CRSP CRISPR THERAPEUTICS AG
IRTC IRHYTHM TECHNOLOGIES INC.
ASML ASML HOLDING N.V.
MDGL MADRIGAL PHARMACEUTICALS
ZLAB ZAI LAB LTD. SPONSORED ADR
MDB MONGODB INC. CLASS A
AAPL APPLE INC.
WGO WINNEBAGO INDUSTRIES INC.
ACMR ACM RESEARCH
KRYS KRYSTAL BIOTECH INC
DBX DROPBOX INC. CLASS A
BTAI BIOXCEL THERAPEUTICS
TENB TENABLE HOLDINGS
CNST CONSTELLATION PHARMACEUTICALS
YMAB Y-MABS THERAPEUTICS
ALLO ALLOGENE THERAPEUTICS
TBIO TRANSLATE BIO
MRNA MODERNA INC.
AVTR AVANTOR INC.
NBSE NEUBASE THERAPEUTICS
GNMSY GENMAB A/S
UI UBIQUITI INC.
DT DYNATRACE INC.
AXLA AXCELLA HEALTH
DDOG DATADOG INC CLASS A
TWST TWIST BIOSCIENCE
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
- Dave Nicoski
- Ross LaDuke
XLRN ACCELERON PHARMA INC
TECH BIO-TECHNE CORPORATION
STX SEAGATE TECHNOLOGY PLC
SNP CHINA PETROLEUM & CHEMICAL CORP. ADS
SLGN SILGAN HOLDINGS INC.
SGEN SEAGEN INC.
RTRX TRAVERE THERAPEUTICS INC.
PBH PRESTIGE CONSUMER HEALTHCARE INC
PAHC PHIBRO ANIMAL HEALTH CORPORATION CLASS A
IPHI INPHI CORPORATION
INGR INGREDION INCORPORATED
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
FTNT FORTINET INC.
ERICn TELEFONAKTIEBOLAGET LM ERICSSON
CTSO CYTOSORBENTS
CTMX CYTOMX THERAPEUTICS INC.
CIEN CIENA CORPORATION
BMY BRISTOL-MYERS SQUIBB COMPANY
BMRN BIOMARIN PHARMACEUTICAL INC.
AUDC AUDIOCODES LTD.
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
A AGILENT TECHNOLOGIES INC.
CAT CATERPILLAR INC.
GLD SPDR GOLD TRUST
NVA NUVISTA ENERGY LTD.
HRC HILL-ROM HOLDINGS INC.
RDY DR. REDDY'S LABORATORIES LTD. ADS
VSTO VISTA OUTDOOR INC
UTHR UNITED THERAPEUTICS CORPORATION
KALA KALA PHARMACEUTICALS INC.
RTP.. RIO TINTO PLC ADS (MEXICO)
INVA INNOVIVA INC.
AZN ASTRAZENECA PLC ADS
GNMSY GENMAB A/S
VCR VANGUARD CONSUMER DISCRETIONAR
- Dave Nicoski
- Ross LaDuke
DXCM DEXCOM INC.
DHR DANAHER CORPORATION
ILMN ILLUMINA INC.
MASI MASIMO CORPORATION
XONE EXONE CO
XLRN ACCELERON PHARMA INC
TM.N TOYOTA MOTOR ADS
TECH BIO-TECHNE CORPORATION
STX SEAGATE TECHNOLOGY PLC
SMED SHARPS COMPLIANCE
SGEN SEAGEN INC.
PODD INSULET CORPORATION
PBH PRESTIGE CONSUMER HEALTHCARE INC
NOVA NOVO NORDISK A/S ADS
NVDA NVIDIA CORPORATION
MPWR MONOLITHIC POWER SYSTEMS INC.
MNTA MOMENTA PHARMACEUTICALS INC.
IPHI INPHI CORPORATION
HAE HAEMONETICS CORPORATION
FFIV F5 NETWORKS INC.
EXEL EXELIXIS INC.
ELMD ELECTROMED
CIEN CIENA CORPORATION
CALM CAL-MAINE FOODS INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
ABX. BARRICK GOLD CORPORATION
ABB ABB LTD. ADS
A AGILENT TECHNOLOGIES INC.
BRC BRADY CORPORATION CLASS A
ENTG ENTEGRIS INC.
HMCn HONDA MOTOR ADS
LMT LOCKHEED MARTIN CORPORATION
UTHR UNITED THERAPEUTICS CORPORATION
AXON AXON ENTERPRISE INC
TNDM TANDEM DIABETES CARE
AMD ADVANCED MICRO DEVICES INC.
NKE NIKE INC. CLASS B
LHX L3HARRIS TECHNOLOGIES INC
SQNS SEQUANS COMMUNICATIONS ADR
- Dave Nicoski
- Ross LaDuke
SHOP SHOPIFY INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
NEM NEWMONT CORPORATION
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
BLUE BLUEBIRD BIO INC.
IZZ TAL EDUCATION GROUP SPONSORED ADR CLASS A
XLRN ACCELERON PHARMA INC
WING WINGSTOP INC.
V VISA INC. CLASS A
SNE. SONY CORP. (ADS)
SINA SINA CORP.
RNG RINGCENTRAL INC. CLASS A
RLI RLI CORP.
NVMI NOVA MEASURING INSTRUMENTS LTD
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
NG. NOVAGOLD RESOURCES INC.
NEO NEOGENOMICS INC.
MSCI MSCI INC. CLASS A
MPWR MONOLITHIC POWER SYSTEMS INC.
MELLANOX TECHNOLOGIES LTD.
JD JD.COM INC. SPONSORED ADR CLASS A
IPHI INPHI CORPORATION
INTC INTEL CORPORATION
FTNT FORTINET INC.
FOLD AMICUS THERAPEUTICS INC.
FNV. FRANCO-NEVADA CORPORATION
FAN FABRINET
FDX FEDEX CORPORATION
EXPD EXPEDITORS INTERNATIONAL OF WASHINGTON INC.
ESE ESCO TECHNOLOGIES INC.
EHTH EHEALTH INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
ECHO ECHO GLOBAL LOGISTICS INC
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CTLT CATALENT INC
CDNS CADENCE DESIGN SYSTEMS INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
AU ANGLOGOLD ASHANTI LTD. ADS
ASTE ASTEC INDUSTRIES INC.
ALXN ALEXION PHARMACEUTICALS INC.
CNR. CANADIAN NATIONAL RAILWAY COMPANY
BRK.B BERKSHIRE HATHAWAY INC. CLASS B
HMCn WORKPOINT ENTERTAINMENT PCL
MRTN HONDA MOTOR ADS
NVS.. MARTEN TRANSPORT LTD.
ODFL NOVARTIS AG ADS
WERN OLD DOMINION FREIGHT LINE INC.
WUBA WERNER ENTERPRISES INC.
RDY 58.COM INC. SPONSORED ADR CLASS A
CIA DR. REDDY'S LABORATORIES LTD. ADS
JBHT CITIZENS INC. CL A
EVBG J.B. HUNT TRANSPORT SERVICES INC.
UTHR EVERBRIDGE INC.
YUMC UNITED THERAPEUTICS CORPORATION
ABX.. YUM CHINA HOLDINGS INC.
AXON BARRICK GOLD CORP.
ASML AXON ENTERPRISE INC
WPM ASML HOLDING N.V.
FANH WHEATON PRECIOUS METALS CORP
SE FANHUA ADS (N SHARES)
JNPR SEA ADS
AMD JUNIPER NETWORKS INC.
HMI ADVANCED MICRO DEVICES INC.
ZS HUAMI ADS (N SHARES)
SWCH ZSCALER INC.
AVLR SWITCH
JWA AVALARA INC
PLMR JWA SA
WORK PALOMAR HOLDINGS
ARCT SLACK TECHNOLOGIES INC. CLASS A
YY ARCTURUS THERAPEUTICS HOLDINGS INC
JOYY
INC.
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom†we laid out our gameplan and what we need to see before having confidence that equity markets ar...
AMGN AMGEN INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
ITW ILLINOIS TOOL WORKS INC.
AMN AMN HEALTHCARE SERVICES INC.
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
AAON AAON INC.
XLRN ACCELERON PHARMA INC
WST WEST PHARMACEUTICAL SERVICES INC.
WEC WEC ENERGY GROUP INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
VNET 21VIANET GROUP INC. SPONSORED ADR CLASS A
VIPS VIPSHOP HOLDINGS LTD SPONSORED ADR
TSLA TESLA INC
TMO THERMO FISHER SCIENTIFIC INC.
TDOC TELADOC HEALTH INC.
STMP STAMPS.COM INC.
SGEN SEAGEN INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
RMD RESMED INC.
RGEN REPLIGEN CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
QDEL QUIDEL CORPORATION
POWI POWER INTEGRATIONS INC.
PG PROCTER & GAMBLE COMPANY
NOVA NOVO NORDISK A/S ADS
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
MUSA MURPHY USA INC.
MNST MONSTER BEVERAGE CORPORATION
3KA STRIDE INC.
LMNX LUMINEX CORP
LLY ELI LILLY AND COMPANY
KR KROGER CO.
KMB KIMBERLY-CLARK CORPORATION
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
JD JD.COM INC. SPONSORED ADR CLASS A
INO INOVIO PHARMACEUTICALS INC.
HRL HORMEL FOODS CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GIS GENERAL MILLS INC.
FLO FLOWERS FOODS INC.
EPZM EPIZYME INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
EBS EMERGENT BIOSOLUTIONS INC.
DVA DAVITA INC.
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CLX CLOROX COMPANY
CASY CASEY'S GENERAL STORES INC.
CALM CAL-MAINE FOODS INC.
BIIB BIOGEN INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
ALLT ALLOT LTD
AKAM AKAMAI TECHNOLOGIES INC.
ABC AMERISOURCEBERGEN CORPORATION
SCI SERVICE CORPORATION INTERNATIONAL
APS. APTOSE BIOSCIENCES
BIO BIO-RAD LABORATORIES INC. CLASS A
CCI CROWN CASTLE INTERNATIONAL CORP
ENPH ENPHASE ENERGY INC.
ZNGA ZYNGA INC. CLASS A
TR TOOTSIE ROLL INDUSTRIES INC.
EVBG EVERBRIDGE INC.
WDFC WD-40 COMPANY
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
WMT WALMART INC.
ASML ASML HOLDING N.V.
CODX CO-DIAGNOSTICS
KALA KALA PHARMACEUTICALS INC.
BKI BLACK KNIGHT INC.
ZLAB ZAI LAB LTD. SPONSORED ADR
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
CTXS CITRIX SYSTEMS INC.
RHHBY ROCHE HOLDING AG ADS
RCUS ARCUS BIOSCIENCES
BILI BILIBILI INC. SPONSORED ADR CLASS Z
DOCU DOCUSIGN INC.
ZM ZOOM VIDEO COMMUNICATIONS INC. CLASS A
RAD RITE AID CORPORATION
VAPO VAPOTHERM
CLVT CLARIVATE PLC (A)
BJ BJ'S WHOLESALE CLUB HOLDINGS
VIR VIR BIOTECHNOLOGY
GSX GSX TECHEDU INC. SPONSORED ADR CLASS A
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TPC TUTOR PERINI CORPORATION
SFLY SHUTTERFLY INC.
RUN SUNRUN INC.
PRCP PERCEPTRON INC.
PBF PBF ENERGY INC. CLASS A
OPK OPKO HEALTH INC.
NTAP NETAPP INC.
MLAB MESA LABORATORIES INC.
LOW LOWE'S COMPANIES INC.
HEAR TURTLE BEACH CORP
ETM ENTERCOM COMMUNICATIONS CORP. CLASS A
OVINTIV INC
CPS COOPER-STANDARD HOLDINGS INC.
COLL COLLEGIUM PHARMACEUTICAL INC.
CODI COMPASS DIVERSIFIED HOLDINGS
CHFC TCF FINANCIAL CORPORATION
BUSE FIRST BUSEY CORPORATION
AHH ARMADA HOFFLER PROPERTIES INC.
GIII G-III APPAREL GROUP LTD.
HIL HILL INTERNATIONAL
HOFT HOOKER FURNITURE CORP.
MGM MGM RESORTS INTERNATIONAL
SGMS SCIENTIFIC GAMES CORPORATION
AC ASSOCIATED CAPITAL GROUP
EHI WESTERN ASSET GLOBAL HIGH INCOME FUND
FSFG FIRST SAVINGS FINANCIAL GROUP INC.
TPL TEXAS PACIFIC LAND CORPORATION
AFI ARMSTRONG FLOORING INC.
CNBKA CENTURY BANCORP INC. CL A
HIO WESTERN ASSET HIGH INCOME OPPORTUNITY FUND
ELVT ELEVATE CREDIT
VERI VERITONE INC.
DMLP DORCHESTER MINERALS L.P.
ATNX ATHENEX
ANGI ANGI INC. CLASS A
VBIV VBI VACCINES INC/BC
ODT ODONATE THERAPEUTICS INC
TYME TYME TECHNOLOGIES
CNX CONSOL ENERGY INC.
SFIX STITCH FIX CLASS A
CLBK COLUMBIA FINANCIAL
NICK NICHOLAS FINANCIAL INC.
RUBY RUBIUS THERAPEUTICS
PRVB PROVENTION BIO INC
PRTS U.S. AUTO PARTS NETWORK
SLGG INC.
NAVB SUPER LEAGUE GAMING
NWHM NAVIDEA BIOPHARMACEUTICALS
JILL THE NEW HOME COMPANY
VST J.JILL
INC.
VANSTAR CORPORATION
Acceleron Reports First Quarter 2018 Operating and Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today provided a corporate update and reported financial results for the first quarter ended March 31, 2018. “2018 is an important year for our Company, as we prepare for the upcoming top-line results from our MEDALIST and BELIEVE Phase 3 trials with luspatercept expected mid-year. We and Celgene continue to invest heavily in ...
Acceleron to Participate in Two Healthcare Investor Conferences in May
CAMBRIDGE,Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that senior management will participate in two upcoming healthcare investor conferences in May. Conference Details: Event: Deutsche Bank 43rd Annual Health Care ConferenceDate: Tuesday, May 8, 2018Location: Boston, MA Event: UBS Global Healthcare ConferenceDate/Time: Tuesday, May 22, 201...
Acceleron Receives FDA Fast Track Designation for ACE-083 in Facioscap...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ACE-083, a locally-acting “Myostatin+” muscle agent, for the treatment of patients with facioscapulohumeral muscular dystrophy (FSHD). “This is an important milestone in the development of ACE-083—our lead program within our ...
Acceleron to Webcast First Quarter 2018 Operating and Financial Result...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN) today announced it will host a webcast and conference call on Tuesday, May 8, 2018 at 5:00 p.m. EDT to discuss its first quarter 2018 operating and financial results. The webcast will be accessible under "Events & Presentations" in the Investors/Media page of the company's website at www.acceleronpharma.com. Individuals can participate in the conference call by dialing 877-312-5848 (domestic) or 253-237-1155 (international) and refer to the “Acceleron Fir...
Acceleron Announces ACE-083 Phase 2 Trial Presentation at the American...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that preliminary results from the ongoing Phase 2 trial of ACE-083 in facioscapulohumeral muscular dystrophy (FSHD) are being presented at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, California on April 26, 2018. The oral presentation will include preliminary findings from cohort...
Acceleron Announces Presentations on Lead Product Candidate Luspaterce...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that two abstracts on lead product candidate luspatercept will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, Illinois on June 1-5, 2018. Luspatercept is being developed as part of a global collaboration between Acceleron and Celgene. Poster Presentations a...
Acceleron to Host Educational Webinar with Leading Clinicians to Provi...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that it will host an educational webinar on pulmonary arterial hypertension (PAH) and the Company’s Phase 2 clinical trial of sotatercept in patients with PAH. The webinar will be led by Acceleron’s senior management team and PAH disease experts, Aaron B. Waxman, M.D., Ph.D., and David Badesch, M.D. The webinar is sched...
Acceleron Announces Publication of ACE-083 Phase 1 Trial Results in Mu...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ: XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that the journal Muscle & Nerve has published the final results from the Phase 1 trial of ACE-083, the Company's locally acting, “Myostatin+”, muscle agent. ACE-083 treatment generated dose-dependent mean total muscle volume increases of up to 14.5% in the rectus femoris (RF) and 8.9% in the tibialis anterior (TA) thre...
Acceleron Reports Fourth Quarter and Full Year 2017 Operating and Fina...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2017. “2017 was an important year for Acceleron as we laid out our corporate strategy and vision for future growth. We are committed to building therapeutic area leadership and advancing our clinical program...
Acceleron to Webcast Fourth Quarter and Full Year 2017 Operating and F...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN) today announced it will host a webcast and conference call on Tuesday, February 27, 2018 at 5:00 p.m. EST to discuss its fourth quarter and full year 2017 operating and financial results. The webcast will be accessible under "Events & Presentations" in the Investors/Media page of the company's website at www.acceleronpharma.com. Individuals can participate in the conference call by dialing 877-312-5848 (domestic) or 253-237-1155 (international) and...
Acceleron Announces Appointment of Chief Commercial Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced the appointment of commercial industry leader, Sujay Kango as Chief Commercial Officer (CCO). He brings over 25 years of commercial leadership and expertise, in both biotechnology and large pharmaceutical companies. Throughout his career, Mr. Kango has led multiple global product launches, including Kyprolis® and Remica...
Acceleron to Present at the Leerink Partners 7th Annual Global Healthc...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that members of the management team will present at the Leerink Partners 7th Annual Global Healthcare Conference on February 15, 2018 at 3:30 p.m. EST in New York, NY. A live audio webcast will be available on the Investors/Media page of the Company's website at www.acceleronpharma.com. A replay of the w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.